1. Home
  2. NAMS vs ALIT Comparison

NAMS vs ALIT Comparison

Compare NAMS & ALIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • ALIT
  • Stock Information
  • Founded
  • NAMS 2019
  • ALIT 2017
  • Country
  • NAMS Netherlands
  • ALIT United States
  • Employees
  • NAMS N/A
  • ALIT N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • ALIT Business Services
  • Sector
  • NAMS Health Care
  • ALIT Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • ALIT Nasdaq
  • Market Cap
  • NAMS 2.7B
  • ALIT 3.0B
  • IPO Year
  • NAMS N/A
  • ALIT N/A
  • Fundamental
  • Price
  • NAMS $27.00
  • ALIT $3.78
  • Analyst Decision
  • NAMS Strong Buy
  • ALIT Strong Buy
  • Analyst Count
  • NAMS 10
  • ALIT 7
  • Target Price
  • NAMS $41.40
  • ALIT $9.07
  • AVG Volume (30 Days)
  • NAMS 872.1K
  • ALIT 8.8M
  • Earning Date
  • NAMS 08-06-2025
  • ALIT 08-05-2025
  • Dividend Yield
  • NAMS N/A
  • ALIT 4.25%
  • EPS Growth
  • NAMS N/A
  • ALIT N/A
  • EPS
  • NAMS N/A
  • ALIT N/A
  • Revenue
  • NAMS $64,006,000.00
  • ALIT $2,311,000,000.00
  • Revenue This Year
  • NAMS N/A
  • ALIT $0.73
  • Revenue Next Year
  • NAMS N/A
  • ALIT $3.11
  • P/E Ratio
  • NAMS N/A
  • ALIT N/A
  • Revenue Growth
  • NAMS 762.15
  • ALIT N/A
  • 52 Week Low
  • NAMS $14.06
  • ALIT $3.62
  • 52 Week High
  • NAMS $27.29
  • ALIT $8.93
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 67.63
  • ALIT 32.49
  • Support Level
  • NAMS $24.41
  • ALIT $3.75
  • Resistance Level
  • NAMS $25.65
  • ALIT $4.15
  • Average True Range (ATR)
  • NAMS 1.10
  • ALIT 0.15
  • MACD
  • NAMS 0.05
  • ALIT 0.06
  • Stochastic Oscillator
  • NAMS 98.63
  • ALIT 20.43

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.

Share on Social Networks: